Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-001952
Filing Date
2018-07-16
Accepted
2018-07-16 08:06:10
Documents
31
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-053118.htm 10-Q 401647
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 9943
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 9953
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 5047
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 4899
6 GRAPHIC image1.jpg GRAPHIC 46805
  Complete submission text file 0001683168-18-001952.txt   1076614

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cnbx-20180531.xml EX-101.INS 57599
8 XBRL SCHEMA FILE cnbx-20180531.xsd EX-101.SCH 9745
9 XBRL CALCULATION FILE cnbx-20180531_cal.xml EX-101.CAL 24089
10 XBRL DEFINITION FILE cnbx-20180531_def.xml EX-101.DEF 13216
11 XBRL LABEL FILE cnbx-20180531_lab.xml EX-101.LAB 81720
12 XBRL PRESENTATION FILE cnbx-20180531_pre.xml EX-101.PRE 59625
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 18953579
SIC: 2834 Pharmaceutical Preparations